1031 related articles for article (PubMed ID: 17983809)
1. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
2. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
4. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression.
Du J; Liang X; Liu Y; Qu Z; Gao L; Han L; Liu S; Cui M; Shi Y; Zhang Z; Yu L; Cao L; Ma C; Zhang L; Chen Y; Sun W
Cell Death Differ; 2009 Feb; 16(2):219-29. PubMed ID: 18927587
[TBL] [Abstract][Full Text] [Related]
6. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
Aly HH; Watashi K; Hijikata M; Kaneko H; Takada Y; Egawa H; Uemoto S; Shimotohno K
J Hepatol; 2007 Jan; 46(1):26-36. PubMed ID: 17112629
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
8. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in hepatitis C virus infection.
Bantel H; Schulze-Osthoff K
Cell Death Differ; 2003 Jan; 10 Suppl 1():S48-58. PubMed ID: 12655346
[TBL] [Abstract][Full Text] [Related]
10. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
[TBL] [Abstract][Full Text] [Related]
11. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
12. Host cell responses induced by hepatitis C virus binding.
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
[TBL] [Abstract][Full Text] [Related]
13. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
[TBL] [Abstract][Full Text] [Related]
14. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells.
Tu Z; Pierce RH; Kurtis J; Kuroki Y; Crispe IN; Orloff MS
Gastroenterology; 2010 Jan; 138(1):305-14. PubMed ID: 19769973
[TBL] [Abstract][Full Text] [Related]
16. STAT3 induces anti-hepatitis C viral activity in liver cells.
Zhu H; Shang X; Terada N; Liu C
Biochem Biophys Res Commun; 2004 Nov; 324(2):518-28. PubMed ID: 15474458
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and pathogenesis of viral hepatitis C--an update.
Nasir A; Arora HS; Kaiser HE
In Vivo; 2000; 14(1):297-300. PubMed ID: 10757089
[TBL] [Abstract][Full Text] [Related]
18. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.
Inoue Y; Murakami K; Hmwe SS; Aizaki H; Suzuki T
Jpn J Infect Dis; 2007 Jul; 60(4):173-8. PubMed ID: 17642525
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles.
Dou J; Liu P; Wang J; Zhang X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1794-800. PubMed ID: 17074016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
